View on NEJM Aronne LJ, Sattar N, Horn DB, et al
Getting the dosage right is crucial to managing potential side effects and ensuring a smoother journey towards achieving your goals
If retatrutide is approved for T2D or cardiovascular outcomes (similar to semaglutides SELECT-based label expansion), those indications would be covered like Mounjaro is now
Hormonal Regulation Stabilising insulin and oestrogen levels may help with: Less uterine muscle hyperstimulation Fewer prostaglandin surges (compounds linked to cramping) Could Mounjaro Make Cramps Worse
But Azagury said thats not a reason to shy away from the medications
Most GLP-1 agonists clear from your bloodstream within 4 to 7 days, though individual timelines depend on dosage, frequency, and your body's metabolic rate